Basic information Safety Supplier Related
ChemicalBook >  Product Catalog >  Pharmaceutical intermediates >  Heterocyclic compound >  Piperazine, 1-(cyclopropylcarbonyl)-, Monohydrochloride

Piperazine, 1-(cyclopropylcarbonyl)-, Monohydrochloride

Basic information Safety Supplier Related

Piperazine, 1-(cyclopropylcarbonyl)-, Monohydrochloride Basic information

Product Name:
Piperazine, 1-(cyclopropylcarbonyl)-, Monohydrochloride
Synonyms:
  • (Cyclopropyl)(piperazin-1-yl)methanone hydrochloride
  • Piperazine, 1-(cyclopropylcarbonyl)-, Monohydrochloride
  • 1-(Cyclopropylcarbonyl)piperazine hydrochloride, [(Piperazin-1-yl)carbonyl]cyclopropane hydrochloride
  • Cyclopropyl(piperazin-1-yl)methanone hydrochloride 97%
  • OlaparibIntermediate
  • 1- cyclopropylmethyl-formyl piperazine hydrochloride
  • 1-(CYCLOPROPANECARBONYL)PIPERAZINE HCl
  • (Cyclopropylcarbonyl)piperazine hydrochloride
CAS:
1021298-67-8
MF:
C8H15ClN2O
MW:
190.67
EINECS:
810-996-6
Mol File:
1021298-67-8.mol
More
Less

Piperazine, 1-(cyclopropylcarbonyl)-, Monohydrochloride Chemical Properties

Melting point:
175-179℃
storage temp. 
Inert atmosphere,Room Temperature
Water Solubility 
Soluble in water
form 
powder to crystal
color 
White to Orange to Green
InChI
InChI=1S/C8H14N2O.ClH/c11-8(7-1-2-7)10-5-3-9-4-6-10;/h7,9H,1-6H2;1H
InChIKey
WIHDAPMHNYYTOA-UHFFFAOYSA-N
SMILES
C(N1CCNCC1)(C1CC1)=O.Cl
CAS DataBase Reference
1021298-67-8
More
Less

Safety Information

HS Code 
2933599590
More
Less

Piperazine, 1-(cyclopropylcarbonyl)-, Monohydrochloride Usage And Synthesis

Uses

1-(Cyclopropylcarbonyl)piperazine Hydrochloride is a reagent used in the synthesis of Esaprazole analogs showing σ1 binding and neuroprotective properties in vitro.

Synthesis

414910-15-9

1021298-67-8

The general procedure for the synthesis of cyclopropyl (piperazin-1-yl)methanone hydrochloride from tert-butyl 4-(cyclopropanecarbonyl)piperazine-1-carboxylate was as follows: to a stirring solution of tert-butyl 4-(cyclopropanecarbonyl)piperazine-1-carboxylate (3.7 g, 14.5 mmol) in methanol (15 mL) was added slowly at 0 °C a hydrochloric acid/methanol solution (15 mL, 3M). After addition, the reaction mixture was stirred at room temperature overnight. Upon completion of the reaction, the solvent was removed by concentration under reduced pressure to afford cyclopropyl (piperazin-1-yl)methanone hydrochloride (2.74 g, 100% yield) as an off-white solid. The product was characterized by 1H-NMR (400 MHz, DMSO-d6): δ 0.71-0.76 (m, 4H), 1.96-2.03 (m, 1H), 3.04-3.16 (m, 4H), 3.69-4.08 (m, 4H), 9.58 (s, 2H); LC-MS (ESI) m/z: 155 (M + 1)+.

References

[1] Patent: US2010/35883, 2010, A1. Location in patent: Page/Page column 56
[2] Patent: WO2011/130661, 2011, A1. Location in patent: Page/Page column 102-103

Piperazine, 1-(cyclopropylcarbonyl)-, MonohydrochlorideSupplier

Jinan XuanDe Chemical Co., Ltd. Gold
Tel
0531-88803958 18866891188
Email
18853169188@163.com
Hangzhou Read Chemical Co., Ltd Gold
Tel
15306818081 15372061639;
Email
sales@freemindpharm.com
Huadong Microbiology Co., Ltd. Gold
Tel
15858880160
Email
dingya@eastchinapharm.com
TIANJIN PHARMACN MEDICAL TECHNOLOGY CO.,LTD.
Tel
022-60189726 18812034280
Email
188120342808@163.com
TCI (Shanghai) Development Co., Ltd.
Tel
021-67121386
Email
Sales-CN@TCIchemicals.com